Unnamed stage
£1.5m
Exonate fundraises £1.5 million
Exonate has closed a £1.5 million round, its fourth, to advance an eye-drop therapy for retinal blood-vessel disease toward clinical trials; backers include Uniseed, Angel CoFund, Wren Capital and O2h Ventures.